中国临床解剖学杂志 ›› 2019, Vol. 37 ›› Issue (5): 517-522.doi: 10.13418/j.issn.1001-165x.2019.05.008

• 实验研究 • 上一篇    下一篇

葛根素对臂丛神经根性撕脱伤脊髓前角iNOS、CGRP蛋白表达及PI3K/Akt信号通路的影响

王雨1, 陈传奇2, 王文晟1, 喻保军1, 张义1, 李丹1, 陈龙菊1   

  1. 1.湖北民族大学医学部解剖学教研室,  湖北   恩施    445000;   2.湖北民族大学附属
    恩施州土家族苗族自治州中心医院妇产科,  湖北  恩施  445000
  • 收稿日期:2019-02-15 出版日期:2019-09-25 发布日期:2019-09-25
  • 通讯作者: 陈龙菊,博士,教授,硕士生导师,Tel:0718-8437479,E-mail:1997029@hbmy.edu.cn
  • 作者简介:王雨(1993-),男,在读硕士,研究方向:中医药治疗周围神经损伤,E-mail:201630160@hbmy.edu.cn
  • 基金资助:
    国家自然科学基金(81260192);湖北民族大学博士科研项目(MY2018B026)

Effects of Puerarin on the expression of iNOS, CGRP, and PI3K/Akt signaling pathway in spinal cord anterior horn after brachial plexus root avulsion injury

WANG Yu1, CHEN Chuan-qi2, WANG Wen-sheng1, YU Bao-jun1, ZHANG Yi1, LI Dan1, CHEN Long-ju1   

  1. 1.Department of Anatomy, Health Science Center, Hubei Minzu University, Enshi 445000, Hubei Province, China; 2.Department of Obstetrics and Gynecology the Central Hospital of Tujia and Miao Autonomous Prefectur,Hubei Minzu University, Enshi 445000, Hubei Province, China
  • Received:2019-02-15 Online:2019-09-25 Published:2019-09-25

摘要: 目的 探讨葛根素对臂丛神经根性撕脱伤(brachial plexus root avulsion injury,BPRAI)脊髓前角iNOS、CGRP蛋白表达及PI3K/Akt信号通路的影响。  方法 将50只雄性SD大鼠随机分为正常组、模型组、葛根素低、中、高剂量治疗组,每组10只。模型组,葛根素低、中、高剂量治疗组进行BPRAI造模,撕脱大鼠右侧C5~7脊神经前根,后根剪断,术后3个治疗组予腹腔注射葛根素,剂量分别为50、100、200 mg·kg-1·d-1,正常组、模型组腹腔注射等体积生理盐水,持续4周。采用尼氏染色、免疫荧光化学、Western blot方法,观察损伤侧脊髓前角α运动神经元(alpha motorneurons,α-MNs)的存活率,iNOS、CGRP、PI3K/Akt通路相关蛋白的表达。  结果 第4周时,低、中、高剂量的葛根素治疗可抑制α-MNs丢失(P<0.05或P<0.01);中、高剂量的葛根素治疗可抑制iNOS表达(P<0.05);高剂量的葛根素治疗可促进CGRP蛋白表达(P<0.05或P<0.01);低、中、高剂量葛根素均可显著抑制p-Akt1/2/3表达(P<0.01)。  结论 葛根素可改善BPRAI造模引起的α-MNs死亡,其机制可能与葛根素能抑制iNOS蛋白的表达、促进CGRP蛋白的表达有关,并且PI3K/Akt信号通路参与其调控。

关键词: 葛根素,  臂丛神经损伤,  α运动神经元,  iNOS,  CGRP,  PI3K/Akt

Abstract: Objective To investigate the effect of Puerarin on the expression of iNOS, CGRP and PI3K/Akt signaling pathway in spinal anterior horn following brachial plexus root avulsion injury (BPRAI).  Methods Fifty SD rats were randomly divided into a normal group, a model group, a low-dose group, a middle-dose group and a high-dose group with 10 rats in each group. BPRAI modeling was made in the model group, low-dose group, middle-dose group and high-dose group by avulsing the anterior roots and transecting posterior roots of right C5~7 segment of spinal nerve. Puerarin was injected intraperitoneally in the low-dose group, middle-dose group and high-dose group after the operation at doses of 50, 100 and 200 mg·kg-1·d-1 respectively. The normal group and model group were given intraperitoneal injection of saline of equal volume for 4 weeks. Nissl staining, immunofluorescence and Western blot were used to observe the survival rate, the expression of iNOS and CGRP of alpha motorneurons (α-MNs), and PI3K/Akt pathway related proteins in the spinal cord on the injured side.    Results    At the 4th week, low, middle and high doses of Puerarin could inhibit the loss of α-MNs (P<0.05 or P<0.01); middle and high doses of Puerarin could inhibit the expression of iNOS (P<0.05); high doses of Puerarin could significantly promote the expression of CGRP protein (P<0.05 or P<0.01); low, middle and high doses of Puerarin could significantly inhibit the expression of p-Akt1/2/3 (P<0.01).  Conclusions    Puerarin can ameliorate the death of alpha-MNs induced by BPRAI. The protective effect of Puerarin may be related to its inhibition of iNOS expression and promotion of CGRP expression, and PI3K/Akt signaling pathway is involved in its regulation.

Key words: Puerarin; ,  Brachial plexus root injury; ,  Alpha motorneurons; ,  iNOS; ,  CGRP; ,  PI3K/Akt

中图分类号: